Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Quantum Biopharma (QNTM) Shares Outstanding (2019 - 2025)

Quantum Biopharma recorded quarterly Shares Outstanding of $42.0 in Q4 2025, down 41.67% quarter-over-quarter from $72.0 in Q4 2021.

Quantum Biopharma's Shares Outstanding history runs 4 years deep, the most recent figure standing at $42.0 for Q4 2025.

  • In Q4 2025, Shares Outstanding changed N/A year-over-year to $42.0; the TTM figure through Dec 2025 stood at $42.0 (changed N/A YoY), while the FY2025 annual figure was $42.0, changed N/A from the prior year.
  • Shares Outstanding came in at $3.9 million for Q4 2025 at Quantum Biopharma, down from $40.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $40.5 million in Q4 2021 to a low of $3.9 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 5.21 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 56.35 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 91.57 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 254.16 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.80 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 133.44 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn - 200.18 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.89 Mn
Dec 31, 2025 42.00
Dec 31, 2025 42.00
Dec 31, 2025 42.00
Dec 31, 2025 3.89 Mn
Dec 31, 2025 3.89 Mn
Dec 31, 2025 3.89 Mn
Dec 31, 2025 42.00
Dec 31, 2021 72.00
Dec 31, 2021 40.45 Mn
Dec 31, 2021 40.45 Mn
Dec 31, 2021 40.45 Mn
Dec 31, 2021 72.00
Dec 31, 2021 72.00
Dec 31, 2021 72.00
Dec 31, 2021 40.45 Mn
Dec 31, 2020 19.16 Mn
Dec 31, 2020 19.16 Mn
Dec 31, 2020 19.16 Mn
Dec 31, 2020 19.16 Mn
Dec 31, 2020 19.16 Mn
Dec 31, 2020 19.16 Mn
Dec 31, 2020 19.16 Mn
Dec 31, 2020 19.16 Mn
Dec 31, 2019 5.35 Mn
Dec 31, 2019 5.35 Mn
Dec 31, 2019 5.35 Mn
Dec 31, 2019 5.35 Mn
Dec 31, 2019 5.35 Mn
Dec 31, 2019 5.35 Mn
Dec 31, 2019 5.35 Mn
Dec 31, 2019 5.35 Mn